Marijuana's Medicinal Value, Brain Science, and Legalization
This paper examines marijuana from multiple angles, arguing that its benefits outweigh its risks when considered in medical, scientific, and policy contexts. Drawing on Michael Pollan's The Botany of Desire, neuroscientific research on cannabinoid receptors, and Drug Policy Alliance data, the paper traces how the U.S. government's crackdown on marijuana inadvertently strengthened indoor cultivation and increased THC potency. It surveys the molecular discovery of THC, the mapping of cannabinoid receptors in the human brain, and the implications for pain management and neuroscience. The paper also explores why marijuana-producing plants may have evolved to satisfy human desires for altered states of consciousness, and concludes by situating these findings within broader debates over medical marijuana legalization.
- Introduction: Marijuana's Risk Profile and the Case for Regulation: Marijuana's relative safety and the need for regulatory frameworks
- Government Crackdown and Its Unintended Consequences: How the War on Drugs inadvertently boosted indoor cannabis cultivation
- THC's Molecular Structure and the Discovery of Cannabinoid Receptors: Discovery of THC and mapping of cannabinoid receptors in the brain
- Evolutionary Reasons for Cannabis and Altered States of Consciousness: Why cannabis evolved to alter human consciousness and perception
- Conclusion: Medical Legalization and the Science of Marijuana: Growing support for medical legalization and policy reform worldwide
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper integrates multiple disciplines — pharmacology, evolutionary biology, neuroscience, and drug policy — into a coherent argument for reassessing marijuana's legal and medical status.
- It supports claims with a diverse range of sources, including literary analysis (Pollan), peer-reviewed neuroscience (Herkenham, Matsuda), and public health data (DPA), lending credibility across different argumentative registers.
- The paper's thesis is clearly stated and consistently returned to, giving the essay a focused through-line despite its broad subject matter.
Key academic technique demonstrated
The paper demonstrates effective use of extended quotation paired with analytical commentary. Rather than simply dropping in block quotes, the student follows each passage — particularly from Pollan — with an explanation of its significance to the overarching argument about policy failure or plant evolution. This shows the reader not just what was said, but why it matters to the paper's thesis.
Structure breakdown
The paper opens with an introduction establishing marijuana's risk profile relative to other substances, followed by a clear thesis statement. Three numbered body sections address, respectively: (1) U.S. drug policy and its backfire effect; (2) the molecular science of THC and cannabinoid receptor discovery; and (3) the evolutionary and psychological dimensions of cannabis-induced altered consciousness. A concluding summary ties these threads to contemporary legalization debates.
Introduction: Marijuana's Risk Profile and the Case for Regulation
Marijuana is not as lethal to human beings as cigarettes or alcohol. It is much less addictive and is generally consumed in far lesser quantities. It is also not strongly linked to accidents, risky sexual conduct, or violence in the way alcohol is. Critically, no one can die from a marijuana overdose. While a small share of individuals who consume marijuana do develop addiction, this issue can be effectively treated. In medicinal form, marijuana has proven effective in dealing with various acute symptoms, including those associated with wasting diseases, nausea, and vomiting. Marijuana is very commonly used throughout the United States (DPA).
The marijuana sold and used across the nation varies greatly in quality and may contain potentially dangerous levels of adulterants or pesticides. The Drug Policy Alliance (DPA) supports the implementation of a regulatory framework for controlling potency, educating consumers through labeling, and protecting against toxic pesticides or additives. Appropriate regulation could govern the product at every stage — from cultivation to preparation, packaging, and distribution — thereby protecting consumers and reducing accessibility to minors. Marijuana prohibition fails to offer these protections (DPA).
A total of 14 states have implemented regulations permitting marijuana's use as a medicine for treating diseases such as cancer, AIDS, glaucoma, and multiple sclerosis. Although studies focusing on marijuana's likely medicinal applications have been restricted domestically, international scientific research has identified an increasing number of advantages of the substance (DPA). Organizations including the American Nurses Association, American Public Health Association, Leukemia and Lymphoma Society, National Association of People with AIDS, AIDS Action Council, American Academy of HIV Medicine, and Lymphoma Foundation of America have all supported medical marijuana access. Moreover, the American Medical Association, in 2009, adopted a resolution calling on the government to reconsider its marijuana classification in order to facilitate additional research into marijuana's medicinal applications (DPA).
Thesis: The plant marijuana has been considered damaging and even potentially fatal to human beings; however, on the basis of its medicinal advantages and economic value, cannabis displays several positives that outweigh its negatives.
Bibliography
DPA. Marijuana and Health. New York: Drug Policy Alliance, n.d.
FOCUS. U.S. Government Position on Cannabis/Marijuana. 2017. Accessed 13 June 2018.
Herkenham, M. "Cannabinoid Receptor Localization in Brain: Relationship to Motor and Reward Systems." In P.W. Kalivas and H.H. Samson (eds.), The Neurobiology of Drug and Alcohol Addiction, Annals of the American Academy of Sciences. 654: 19–32, 1992. p. 19.
Herkenham, M., Lynn, A.B., et al. "Cannabinoid Receptor Localization in Brain." Proceedings of the National Academy of Sciences, 87: 1932–1936, 1990.
Johansson, E., Halldin, M.M., Agurell, S., Hollister, L.E., Gillespie, H.K. "Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana." European Journal of Clinical Pharmacology 37(3): 273–277. PMID 2558889. 1989.
Lichtman, A.H., Martin, B.R. "Spinal and Supraspinal Components of Cannabinoid-Induced Antinociception." Journal of Pharmacology and Experimental Therapeutics. 258: 517–523. 1991.
Martin, B.R. "Cellular Effects of Cannabinoids." Pharmacological Reviews 38: 45–74. p. 46. 1986.
Matsuda, L., Lolait, S., et al. "Structure of a cannabinoid receptor and functional expression of the cloned cDNA." Nature 346: 561–564. 1990.
Newman, Tony. Connecting the Dots: 10 Disastrous Consequences of the Drug War. 01 February 2013. Accessed 13 June 2018.
Pollan, Michael. The Botany of Desire: A Plant's-Eye View of the World. London: Bloomsbury, 2003.
Sznitman, Sharon and Anne Line Bretteville-Jensen. "Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies." Harm Reduct J. (2015).
Tart, Charles T. "Scientific foundations for the study of Altered States of Consciousness." ATPWeb (1971).
Thomas, B., Compton, D., Martin, N. "Characterization of the Lipophilicity of Natural and Synthetic Analogs of D9-Tetrahydrocannabinol and Its Relationships to Pharmacological Potency." Journal of Pharmacology and Experimental Therapeutics. 255(2): 624–630. 1990.
Create your account
Always verify citation format against your institution’s current style guide requirements.